Can telehealth at syringe exchanges boost HIV prevention for drug users?

NCT ID NCT07433712

Recruiting now Knowledge-focused Sponsor: University of Minnesota Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a program called Project REACH, which offers telehealth services at syringe service programs (places where people can get clean needles). The goal is to see if this makes it easier for people who use drugs to get HIV prevention (like PrEP) and addiction treatment. About 121 participants will be enrolled and followed for 6 months to see if the program is practical and helpful.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: telehealth intervention
What this could lead to: If successful, this could show that offering telehealth at syringe service programs helps more people access HIV prevention and addiction treatment.
What could go wrong: This is a small pilot study (121 people) focused on feasibility, not proof of effectiveness. Results may not apply to other settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

substance abuse substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRUG USE SUBSTANCE USE

Contacts and locations

Locations

University of Minnesota
RECRUITING

Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.